Interoperability, Medicaid fraud, Premier's latest financial results and a listening session on proposed changes to Medicare's physician fee schedule will be in the news this week.
A mobile fertility app is the first ever digital contraceptive device to win FDA marketing approval. But reports of unwanted pregnancies and investigations in Europe have raised questions about marketing what is essentially a health monitor as a contraceptive.
The country's largest public health information exchange will use Verato's Universal MPI for referential patient matching, which it says will reduce uncertainty when linking patients to their health data.
Google, Amazon, Microsoft, IBM, Oracle and Salesforce came together to push more comprehensive health data exchange, which they said will improve outcomes and lower costs.
To cut back on predatory marketing of addiction treatment centers, Facebook will require such centers to go through a certification and application process. Google has already implemented a similar policy.
The ONC and CMS are pushing efforts to broaden and deepen interoperability by giving patients more control of their health data, including through the CMS' MyHealthEAll about medicine initiative.
Cerner Corp. grew its revenue and bookings in the second quarter, during which it signed a long-delayed contract with the VA to replace its EHR.
Allscripts' revenue hit $526 million in the second quarter of 2018, a period during which the vendor closed a $60 million deal to acquire HealthGrid.
For the second time this year, UnityPoint employees have fallen for email phishing scams. This time, hackers may have accessed 1.4 million patients' information, including some financial data.
The industry is carefully attuned to provider wellness, and this is important. We know this burden has a negative impact on healthcare. We need to think more broadly and reduce nurses' burden as well.
The Icahn School of Medicine at Mount Sinai's new center will be able to add a level of academic rigor to the discussion about blockchain in healthcare.
NIH and FDA researchers increasingly depend on data from an array of sources, and they want to bring real-world evidence into their work. That includes the NIH's All of Us precision-medicine initiative.